Erik Henricksen, PharmD
Stanford Medicine
Stanford, CA USA
Bye-Bye Biopsy? Comparing Short and Long-Term Outcomes after Adopting Early Non-Invasive Rejection Surveillance
2023 Pharmacy Professional Community Award for Excellence Winner